New publication on health-related quality of life in Parkinson’s disease
A new registry-based study from IHE has evaluated if clinical outcomes and health-related quality of life (HRQoL) in Parkinson’s disease differ depending on whether patients meet the so-called 5-2-1 criteria. The criteria, which are based on motor symptoms, aim to identify patients with insufficient symptom control from oral medication. The results indicate a higher disease burden and significantly lower HRQoL among the 365 patients (36% of the total study population) who met the criteria. This delineates a group of patients for whom further investigation for DAT candidacy or other optimizations of treatments may be indicated.
